Viking Therapeutics, Inc. (VKTX)

[Michael Scally MD]

Viking Therapeutics, Inc. (VKTX)
Viking Therapeutics
VKTX : Summary for Viking Therapeutics, Inc. - Yahoo Finance

[Basically, a LGND spin-off. IMO, ultimate failure. But a possible trade for profit. Be Careful.

Our lead clinical program is VK5211, a novel, orally available, non-steroidal selective androgen receptor modulator, or SARM, in Phase 2 development for the treatment of patients recovering from non-elective hip fracture surgery.

Viking Therapeutics Announces Positive Top-Line Results from Phase 2 Study of VK5211 in Patients Recovering from Hip Fracture
Viking Therapeutics Announces Positive Top-Line Results from Phase 2 Study of VK5211 in Patients Recovering from Hip Fracture

 

[rugerjitsu]

Viking Therapeutics, Inc. (VKTX)
Viking Therapeutics
VKTX : Summary for Viking Therapeutics, Inc. - Yahoo Finance

[Basically, a LGND spin-off. IMO, ultimate failure. But a possible trade for profit. Be Careful.

Our lead clinical program is VK5211, a novel, orally available, non-steroidal selective androgen receptor modulator, or SARM, in Phase 2 development for the treatment of patients recovering from non-elective hip fracture surgery.

Viking Therapeutics Announces Positive Top-Line Results from Phase 2 Study of VK5211 in Patients Recovering from Hip Fracture
Viking Therapeutics Announces Positive Top-Line Results from Phase 2 Study of VK5211 in Patients Recovering from Hip Fracture

Buy now, and sell after earnings bump this week??

 

[Michael Scally MD]

Buy now, and sell after earnings bump this week??

Whoops ...

 

[rugerjitsu]

Whoops ...

Whoops is right! So much manipulation anymore with these types of stocks.

 

[rugerjitsu]

Boom!!

 

[Michael Scally MD]

Boom!!

Riding the shirt tail of MDGL. Profit but be careful. Their drug will not be approved. Nor, can they afford the trials so maybe hope for a buyout [doubtful].

 

[Michael Scally MD]

 

[Michael Scally MD]

Boom!!

Riding the shirt tail of MDGL. Profit but be careful. Their drug will not be approved. Nor, can they afford the trials so maybe hope for a buyout [doubtful].

Caveat Emptor ...

Viking Therapeutics: Sell The Pop On The Sympathy Play
Viking Therapeutics: Sell The Pop On The Sympathy Play - Viking Therapeutics (NASDAQ:VKTX) | Seeking Alpha

· VKTX rose as a sympathy play to MDGL as investors surmise that the good data on MGL-3196 increases the probability of success for VK2089.

· VKTX has had substantial dilution of more than 100% over the last year at much lower prices to today which I think will be a significant overhang.

· Most perilously, VKTX has an open at-the-market common share purchase agreement with Lincoln Park Capital Fund, a fund known for dilutive financing deals.

· I expect VKTX's stock to decline in the coming days to a price marginally above where it was prior to Thursday.

 

[rugerjitsu]

I’ve been keeping my eye on it, but was never remotely close to putting money in it. Just thought I would bump the thread with the recent increase!

 

[rugerjitsu]

bam!!

 

[maxmuscle01]

VKTX has developed a sarm or peptide that is improving NASH and fatty liver. If it passes trials it will be worth a fortune. I am keeping up to date on this new drug.

 

[Michael Scally MD]

Citron Publishes the Smoking Gun on Ligand Pharmaceuticals
Citron Publishes the Smoking Gun on Ligand Pharmaceuticals - Citron Research

[$VKTX SCAM]

 

[maxmuscle01]

Citron Publishes the Smoking Gun on Ligand Pharmaceuticals
Citron Publishes the Smoking Gun on Ligand Pharmaceuticals - Citron Research

[$VKTX SCAM]

View attachment 104369

View attachment 104370

View attachment 104371

It’s such a scam nowadays! I hate to see these companies try and steal our $$